GW Henssler & Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$333K Sell
6,358
-12
-0.2% -$469 0.01% 172
2026
Q1
$225K Buy
+6,370
New +$198K 0.01% 203
2025
Q4
Sell
-6,680
Closed -$200K 235
2025
Q3
$200K Buy
+6,680
New +$188K 0.01% 226

Other funds holding ALKS

GW Henssler & Associates's ALKS Position: Q2 2026 in Review

GW Henssler & Associates reduced its Alkermes (ALKS) stake by 0.19% in Q2 2026, selling an estimated $469 and leaving 6,358 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #172.

GW Henssler & Associates first reported a position in ALKS in Q3 2025 and has held it in 3 quarters since. 425 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • GW Henssler & Associates held 6,358 shares of Alkermes worth $333K as of Q2 2026.
  • GW Henssler & Associates sold 12 Alkermes shares in Q2 2026, an estimated $469.
  • Alkermes made up 0.01% of GW Henssler & Associates's portfolio in Q2 2026, its #172 holding.
  • GW Henssler & Associates first reported a position in Alkermes in Q3 2025 and has held it in 3 quarters since.
  • 425 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on GW Henssler & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.